Physician

Amged Abdelmonim Tagelsir Abdelaziz, MD

According to 2025 Medicare claims, Amged Abdelaziz, MD (NPI: 1972703536) practices interventional cardiology in the Detroit-Dearborn-Livonia, MI market, with the plurality of this provider's patient population coming from Wayne, MI. This provider's primary affiliated billing organization is ARK CARDIOVASCULAR & ARRHYTHMIA CENTER PLC (NPI: 1538584495; TIN: 464805855) and primary practice location at 48183-1959. Abdelaziz is affiliated with the Arvon CIN (ACO ID: A1095) and McLaren High Performance Network, LLC (ACO ID: A3317), participating under the MSSP model.

Abdelaziz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 556 traditional Medicare patients, billed 1,970 HCPCS/CPT codes, and received $156,661 in Medicare payments. The top billing code was 93458 (Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist). Part D data shows 1,700 prescription claims across 344 beneficiaries totaling $289,244 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 40 records totaling $1,167. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $1,533 to $156,661. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $3,525 and ending at $289,244. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	33	43	$1,533
2019	265	449	$21,052
2020	166	377	$42,575
2021	598	1,721	$145,183
2022	372	1,242	$82,476
2023	99	327	$33,231
2024	556	1,970	$156,661

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	29	66	$3,525
2016	37	108	$7,126
2017	24	123	$7,350
2018	13	33	$1,800
2019	N/R	15	$168
2020	15	30	$780
2021	45	106	$3,475
2022	59	238	$35,884
2023	30	72	$6,068
2024	344	1,700	$289,244

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93458	Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist	31	32	$201
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	106	108	$87
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	169	356	$68
99221	Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes	131	144	$63
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	265	909	$62

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	105	4,365	$82,086
Xarelto	Rivaroxaban	46	2,639	$47,009
Entresto	Sacubitril/Valsartan	50	1,889	$40,919
Farxiga	Dapagliflozin Propanediol	50	2,148	$39,169
Jardiance	Empagliflozin	22	840	$15,952

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	40	$1,167	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amged Abdelmonim Tagelsir Abdelaziz, MD?

Tedicare shows public-source Medicare data for Amged Abdelmonim Tagelsir Abdelaziz, MD (NPI 1972703536), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amged Abdelmonim Tagelsir Abdelaziz, MD have ACO affiliation data?

Amged Abdelmonim Tagelsir Abdelaziz, MD is shown with ACO affiliation data for Arvon CIN (MSSP, ACO ID A1095) and McLaren High Performance Network, LLC (MSSP, ACO ID A3317).

What billing organization is linked to Amged Abdelmonim Tagelsir Abdelaziz, MD?

Amged Abdelmonim Tagelsir Abdelaziz, MD is linked to ARK CARDIOVASCULAR & ARRHYTHMIA CENTER PLC (billing NPI 1538584495) in the available physician profile data.

Does Amged Abdelmonim Tagelsir Abdelaziz, MD have Open Payments data?

Amged Abdelmonim Tagelsir Abdelaziz, MD has 40 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.